NSCLC
Tafinlar (Dabrafenib Mesylate) – Melanoma & Lung Cancer | DengYue Medicine
Augtyro (Repotrectinib) – NSCLC | HongKong DengYue Medicine
Unecritinib Fumarate – NSCLC | DengYue Medicine
Exkivity (Mobocertinib) – NSCLC | HongKong DengYue Medicine
Purocenta (Para‑toluenesulfonamide) – NSCLC | DengYueMed
Cejemly (Sugemalimab) – NSCLC | DengYue Medicine
Gavreto (Pralsetinib) – NSCLC | HongKong DengYue Medicine
Ameile (Aumolertinib Mesylate) – NSCLC | DengYueMed
Tevimbra (Tislelizumab-jsgr) – NSCLC | DengYueMed
Mekinist (Trametinib) – NSCLC | DengYue Medicine
Tafinlar (Dabrafenib) – NSCLC | DengYue Medicine
Imfinzi (Durvalumab) – NSCLC | DengYue Medicine
Camrelizumab – NSCLC | HongKong DengYue Medicine
Vizimpro (Dacomitinib) – NSCLC | HongKong DengYue Medicine
Keytruda (Pembrolizumab) – NSCLC | HongKong DengYue Medicine
Opdivo (Nivolumab) – NSCLC | HongKong DengYue Medicine
